LAVAL, Quebec, Nov. 8, 2017 /CNW/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)
("Valeant") today announced that Joseph C.
Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and
head of Investor Relations and Communications, are scheduled to
participate at the Stifel 2017 Healthcare Conference in
New York on Nov. 14, 2017 at 2:45 p.m.
EST.
A live webcast and audio archive of the event will be available
on the Investor Relations page of the Valeant web site at:
http://ir.valeant.com/events-and-presentations/2017.
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, gastrointestinal disorders,
eye health, neurology and branded generics. More information about
Valeant can be found at www.valeant.com.
|
Investor
Contact:
|
|
Media
Contact:
|
|
Arthur
Shannon
|
|
Lainie
Keller
|
|
arthur.shannon@valeant.com
|
|
lainie.keller@valeant.com
|
|
(514)
856-3855
|
|
(908)
927-0617
|
|
(877) 281-6642 (toll
free)
|
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/valeant-to-participate-at-the-stifel-2017-healthcare-conference-300552508.html
SOURCE Valeant Pharmaceuticals International, Inc.